[HTML][HTML] Association of factors influencing selection of upfront hematopoietic cell transplantation versus nontransplantation therapies in myelofibrosis
E Smith, J Huang, A Viswabandya, D Maze… - … and Cellular Therapy, 2021 - Elsevier
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
[HTML][HTML] Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis
E Smith, J Huang, A Viswabandya, D Maze… - … and Cellular Therapy …, 2021 - tctjournal.org
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis
E Smith, J Huang, A Viswabandya… - Transplantation …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
E Smith, J Huang, A Viswabandya, D Maze… - … and Cellular Therapy, 2021 - europepmc.org
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
[HTML][HTML] Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis
E Smith, J Huang, A Viswabandya, D Maze… - … and Cellular Therapy …, 2021 - astctjournal.org
Despite the curative potential of allogeneic hematopoietic cell transplantation (HCT) for
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …
myelofibrosis (MF), a significant number of patients with MF do not undergo HCT. Factors …